Effect of probiotics combined with immune checkpoint suppressors and chemotherapeutic agents on digestive system function, intestinal immunity and prognosis in patients with metastatic colorectal carcinoma: a quasi-experimental study
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
An exploration of the influence of probiotics combined with immune checkpoint suppressors and chemotherapeutic agents on digestive system function, intestinal immunity and prognosis in patients with metastatic colorectal carcinoma. This was a quasi-experimental study. During March 2019 to March 2020, 96 patients with metastatic colorectal carcinoma were arbitrarily classified into control group ( n = 48) and intervention group ( n = 48). The control group received only immune checkpoint inhibitors or chemotherapy, while the intervention group received immune checkpoint inhibitors or chemotherapy, plus probiotic therapy. Survival and complication rates after 6 months, 12 months and 2 years of treatment were calculated. Intestinal barrier function, immune function and quality of life were analyzed before and after treatment. Ninety-six patients were recorded at the follow-up demonstrating superior survival in the intervention group after 6 months, 12 months and 2 years of therapy. D-lactate and diamine oxidase (DAO) levels were elevated in the intervention group after treatment, with smaller elevations ( P < 0.05). The levels of Bifidobacterium and Lactobacillus were remarkably higher in the intervention group after treatment compared to the control group prior to and following therapy ( P < 0.05). The amount of Enterococcus and Escherichia coli in the intervention group after treatment was obviously lower compared to the pre-treatment and control groups ( P < 0.05). CD3 + , CD4 + , and CD4 + /CD8 + levels were found to be higher in the intervention group ( P < 0.05), while CD8 + levels were reduced in the intervention group ( P < 0.05). All dimensions of the QLQC-30 scale were higher in the intervention group ( P < 0.05). The incidence of complications such as nausea and vomiting, loss of appetite, bloating and diarrhea was considerably reduced in the intervention group ( P < 0.05). Immune checkpoint suppressors combined with chemotherapeutic agents or probiotic regimens can obviously enhance the prognosis of patients with metastatic colorectal carcinoma. This combination therapeutic strategy can balance the imbalanced intestinal flora, improve intestinal function, and lessen the incidence of adverse events, so it is worthy of clinical application and can lessen the incidence of adverse reactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For instance, in clinical trials conducted on metastatic colorectal cancer patients treated with chemotherapy or ICB, administration of live Bifidobacterium spp. reduced treatment complications such as nausea and vomiting, loss of appetite, bloating, or diarrhea (Wang et al., 2025).”
From Microbiota-centered interventions to boost immune checkpoint blockade therapies (2025) · cites this paper as Wang et al., 2025
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Christensen, H. R., Frøkiær, H., & Pestka, J. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.171 · Cited by 902
Sahin, I. H., Akce, M., Alese, O., Shaib, W., Lesinski, G. B., El-Rayes, B., & Wu, C. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0599-y · Cited by 393 · cited 1×
“Immune checkpoints can downregulate T cell signaling, prevent T cell proliferation and maintain tolerance to self-antigens, thereby suppressing immune system activation and helping tumor cells evade host immune surveillance [4].”
Knight, S. R., Shaw, C. A., Pius, R., Drake, T. M., Norman, L., Ademuyiwa, A. O., Adisa, A. O., Aguilera, M. L., Al-Saqqa, S. W., Al-Slaibi, I., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00001-5 · Cited by 328 · cited 1×
“Epidemiological surveys worldwide have demonstrated that the prevalence of colorectal cancer is mainly affected by food, obesity, exercises, and lifestyle [3].”
Multi-Strain Probiotics: Synergy among Isolates Enhances Biological Activities
Kwoji, I. D., Aiyegoro, O. A., Okpeku, M., & Adeleke, M. A. (2021) · Biology · doi:10.3390/biology10040322 · Cited by 225 · cited 1×
“Research indicates that multi-strain probiotics may offer benefits beyond those of single-strain products due to potential synergistic interactions among strains [31].”
Brown, S. R., Mathew, R., Keding, A., Marshall, H. C., Brown, J. M., & Jayne, D. G. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000407 · Cited by 214
McFarland, L. V. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06244-z · Cited by 184 · cited 1×
“Therefore, understanding the distinct roles of individual strains can help design more effective probiotic therapies tailored to specific health conditions [32].”
A synthetic probiotic engineered for colorectal cancer therapy modulates gut microbiota
Chung, Y., Ryu, Y., An, B. C., Yoon, Y.-S., Choi, O., Kim, T. Y., Yoon, J., Ahn, J. Y., Park, H. J., Kwon, S.-K., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01071-4 · Cited by 172 · cited 1×
“The acetic acid, lactic acid and other related organic acids produced by probiotics can improve their biophysical and biochemical environment, inhibit foreign bacteria and maintain the body’s ecological balance [22, 23].”
Hentic, O., Hammel, P., Couvelard, A., Rebours, V, Zappa, M., Palazzo, M., Maire, F., Goujon, G., Gillet, A., Lévy, P., et al. (2012) · Endocrine-Related Cancer · doi:10.1530/erc-12-0002 · Cited by 162 · cited 2×
“Among them, Lactobacillus and Bifidobacterium can specifically combine with the receptors of intestinal epithelial cells to mend the damaged intestinal mucosa and up-regulate the flora balance [18–20].”
Translation and validation of the Standard Chinese version of the EORTC QLQ-C30
Zhao, H., & Kanda, K. (2000) · Quality of Life Research · doi:10.1023/a:1008981520920 · Cited by 150 · cited 1×
“Also, in the study of Zhao et al. (2000), the Cronbach’s alpha value of this questionnaire was reported to be 0.70 in the population of Chinese women with cancer [21].”
InfluentialThe Role of Probiotics in Colorectal Cancer Management
Sivamaruthi, B. S., Kesika, P., & Chaiyasut, C. (2020) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2020/3535982 · Cited by 118
Role of Gut Microbiota and Probiotics in Colorectal Cancer: Onset and Progression
Torres-Maravilla, E., Boucard, A.-S., Mohseni, A. H., Taghinezhad-S, S., Cortes-Perez, N. G., & Bermúdez-Humarán, L. G. (2021) · Microorganisms · doi:10.3390/microorganisms9051021 · Cited by 96 · cited 1×
“Additionally, the toxic effects of chemotherapeutic drugs can dampen the associated inflammatory cells and affect the body’s immunity [14, 15].”
Wierzbicka, A., Mańkowska‐Wierzbicka, D., Mardas, M., & Stelmach-Mardas, M. (2021) · Nutrients · doi:10.3390/nu13041160 · Cited by 72 · cited 1×
“Meanwhile, probiotics may modulate the activities and numbers of T cells, which is beneficial for the regulation of immune function [27, 28].”
Dikeocha, I. J., Al-Kabsi, A. M., Eid, E. E. M., Hussin, S., & Alshawsh, M. A. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab006 · Cited by 60 · cited 1×
“Additionally, the toxic effects of chemotherapeutic drugs can dampen the associated inflammatory cells and affect the body’s immunity [14, 15].”
Cheng, J., Liu, B.-L., Zhang, X., Zhang, Y., Lin, W. J., Wang, R., Zhang, Y., Zhang, H., Xie, L., & Huo, J. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-56 · Cited by 59 · cited 3×
“Among them, Lactobacillus and Bifidobacterium can specifically combine with the receptors of intestinal epithelial cells to mend the damaged intestinal mucosa and up-regulate the flora balance [18–20].”
InfluentialHistone Deacetylase Modifications by Probiotics in Colorectal Cancer
Farrokhi, A. S., Mohammadlou, M., Abdollahi, M., Eslami, M., & Yousefi, B. (2019) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-019-00338-2 · Cited by 56
The Protective Role of Probiotics against Colorectal Cancer
Ding, S., Hu, C., Fang, J., & Liu, G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8884583 · Cited by 54 · cited 1×
“Probiotics promote the recovery of damaged epithelial cells and maintain the integrity of the intestinal mucosa [11].”
Darbandi, A., Mirshekar, M., Shariati, A., Moghadam, M. T., Lohrasbi, V., Asadollahi, P., & Talebi, M. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.11.008 · Cited by 53 · cited 1×
“Probiotics can also stimulate the proliferation of various cytokines and macrophages, regulating the antigen-specific T cell activation and quantity, and directly influencing T cell-mediated inflammatory responses [26].”
Colorectal Cancer and Probiotics: Are Bugs Really Drugs?
Lamichhane, P., Maiolini, M., Alnafoosi, O., Hussein, S., Alnafoosi, H., Umbela, S., Richardson, T., Alla, N., Lamichhane, N., Subhadra, B., et al. (2020) · Cancers · doi:10.3390/cancers12051162 · Cited by 50 · cited 1×
“Probiotics can enhance the micro-ecological balance and health conditions of patients [6].”
Shamekhi, S., Lotfi, H., Abdolalizadeh, J., Bonabi, E., & Zarghami, N. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02270-0 · Cited by 47 · cited 1×
“Previous studies have shown that probiotics can directly compensate for the physiologic flora that patients are deficient in as a result of chemotherapy and surgery, which can maintain intestinal microecology and intestinal barrier functionality [7–9].”
The Effect of Perioperative Administration of Probiotics on Colorectal Cancer Surgery Outcomes
Pitsillides, L. C., Pellino, G., Tekkis, P. P., & Kontovounisios, C. (2021) · Nutrients · doi:10.3390/nu13051451 · Cited by 41
Miknevicius, P., Žulpaitė, R., Leber, B., Strupas, K., Stiegler, P., & Schemmer, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179347 · Cited by 38 · cited 1×
“Patients with colorectal carcinoma receive broad-spectrum antibiotics prior to and subsequent to surgical treatment, resulting in a relatively weakened purgative effect and causing intestinal damage [16].”
Vissers, Y. M., Snel, J., Zuurendonk, P. F., Kleerebezem, M., Wichers, H. J., & Savelkoul, H. F. J. (2010) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2010.00741.x · Cited by 35 · cited 1×
“Therefore, additional experiments, such as ex vivo studies on immune cells and cytokine quantification, could validate these findings and provide deeper insights into the precise mechanisms by which probiotics regulate T-cell function [30].”
Potential Ability of Probiotics in the Prevention and Treatment of Colorectal Cancer
Zhao, J., Liao, Y., Wei, C., Ma, Y., Wang, F., Chen, Y., Zhao, B., Ji, H., Wang, D., & Tang, D. (2023) · Clinical Medicine Insights: Oncology · doi:10.1177/11795549231188225 · Cited by 35 · cited 1×
“Zhao et al. (2023) state in their study that the use of probiotics in patients undergoing abdominal surgery is a promising therapeutic approach in preventing postoperative infection at the surgical site with shallow incisions and improving the integrity of the intestinal mucosal barrier.”
Update on Strategies of Probiotics for the Prevention and Treatment of Colorectal Cancer
Tang, G., & Zhang, L. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2020.1865420 · Cited by 34 · cited 1×
“Furthermore, the microscopic-wrin-kled cells can transport microbial cells to the capsules of macrophages by pinocytosis [25].”
Paneth cells: the hub for sensing and regulating intestinal flora
Zhang, Z., & Liu, Z. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-5018-5 · Cited by 33 · cited 1×
“Specific receptors on the mucosa bind to them, forming a fixed biological barrier and colonising resistance, effectively protecting the body from bacterial invasion [13].”
Insights of probiotics as an alternative medicine for cancer therapy, mechanism, and applications
Mukherjee, S., Kumar, D., & Guha, D. (2024) · Medicine in Microecology · doi:10.1016/j.medmic.2024.100111 · Cited by 25 · cited 1×
“Also, Mukherjee et al. (2023) state in their study that the use of probiotics in cancer patients can reduce the side effects of treatment and increase the patient’s overall quality of life [34].”
Dikeocha, I. J., Al‐Kabsi, A. M., Hussin, S., & Alshawsh, M. A. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038128 · Cited by 15 · cited 1×
“The acetic acid, lactic acid and other related organic acids produced by probiotics can improve their biophysical and biochemical environment, inhibit foreign bacteria and maintain the body’s ecological balance [22, 23].”
Benioudakis, E. S., Karlafti, E., Bekiaridou, Α., Didangelos, T., & Papavramidis, T. S. (2021) · Nutrients · doi:10.3390/nu14010192 · Cited by 15 · cited 1×
“Meanwhile, probiotics may modulate the activities and numbers of T cells, which is beneficial for the regulation of immune function [27, 28].”
Research works printed but not linked: 6
- Lin F, Chao L, Chunhui Z, et al. Research status and treatment strategies of maintenance therapy for metastatic colorectal cancer. J Pract Oncol. 2019;33(02):173–8.
- Enlong W, Sufei Z, Guangran M, et al. Study on the significance of screening for a high-risk population of colorectal cancer in Xingqing District of Yinchuan City. Ningxia Med J. 2018;40(01):58–60.
- Zhang C, Yang W. Multivariate analysis of the efficacy and prognosis of adjuvant chemotherapy in elderly patients with colon cancer after radical resection. Electron J Clin Med Lit. 2019;6(43):79–80.
- Tang L, Liu B. Research progress of intestinal flora in the pathogenesis and treatment of colorectal cancer. Shandong Med. 2022;62(10):101–4.
- Medical Administration of the Health and Family Planning Commission of the people's Republic of China, Oncology Branch of Chinese Medical Association. Chinese norms for diagnosis and treatment of Colorectal Cancer (2017 Edition) [J]. Chin J Surg. 2018;56(04): 241–258.
- Zhao X, Jia Jinsheng LQ. Meta analysis of the preventive and therapeutic effect of probiotics on chemotherapy-associated diarrhea. J Pharmacoepidemiol. 2018;27(6):366–73+409.
Cited by
Sahoo, D., Rodriguez, E., Nguyen, K. T., & Chintapula, U. K. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c00959 · Cited by 32
Wang, X., Cheng, Y., Huang, J., Xu, F., Jiang, J., Nalinratana, N., Jin, L., & Xue, Y. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1696524 · Cited by 31
Microbiota-centered interventions to boost immune checkpoint blockade therapies
Almonte, A. A., Thomas, S., & Zitvogel, L. (2025) · Journal of Experimental Medicine · doi:10.1084/jem.20250378 · Cited by 19
Zhou, S., Liu, Y., Liu, Y., Duan, Z., Zhu, C., Wang, P., & Fu, R. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c06844 · Cited by 18
Enterococcus Species: Multifaceted Probiotic Potential and Safety Considerations
John, O. P., Afolabi, K. O., Ngene, A. C., Tanimowo, W. O., Adewoyin, M. A., Osho, M. B., & Reuben, R. C. (2026) · Microorganisms · doi:10.3390/microorganisms14040815 · Cited by 14
“Some enterococci play a significant role in the gut ecosystem, contributing to immunomodulation, gut health, and metabolic maintenance [35,36].”
Metadata
- Authors
- Wang, X., Huang, Y., Yang, Z., Yang, Y., Wei, F., Yan, M., Li, F., & Wang, C.
- Affiliations
- Second Affiliated Hospital of Anhui Medical University (CN)
- Corresponding author
- Li, Fanfan
- Venue
- BMC Gastroenterology
- Published
- 2025-01-27
- Volume
- 25
- Issue
- 1
- Pages
- 38-38
- ISSN
- 1471-230X (ISSN-L)
- PMC
- PMC11773699
- OpenAlex
- W4406872434
- Cited by
- 18
- References
- 28
- Citations by year
- 2026: 13 · 2025: 5
- FWCI
- 8.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- BMC Gastroenterology (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Keywords
- probiotics, metastatic colorectal cancer, immune checkpoint inhibitors, chemotherapy, intestinal immunity, intestinal barrier function, gut microbiota, Bifidobacterium, Lactobacillus, D-lactate, diamine oxidase, CD4/CD8 ratio, quality of life, treatment-related adverse events, survival
- MeSH terms
- Gastrointestinal Microbiome, Immune Checkpoint Inhibitors, Adult, Aged, Antineoplastic Agents, Female, Amine Oxidase (Copper-Containing), Humans, Male, Middle Aged, Prognosis, Quality of Life, Colorectal Neoplasms, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


